Teacher Retirement System of Texas Sells 12,772 Shares of LivaNova PLC (NASDAQ:LIVN)

Teacher Retirement System of Texas trimmed its stake in shares of LivaNova PLC (NASDAQ:LIVN - Free Report) by 36.7% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 22,019 shares of the company's stock after selling 12,772 shares during the period. Teacher Retirement System of Texas' holdings in LivaNova were worth $1,020,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Nordea Investment Management AB increased its holdings in shares of LivaNova by 22.2% in the fourth quarter. Nordea Investment Management AB now owns 68,711 shares of the company's stock worth $3,188,000 after purchasing an additional 12,470 shares during the last quarter. Harbor Capital Advisors Inc. purchased a new position in LivaNova during the 4th quarter valued at approximately $1,954,000. KBC Group NV grew its holdings in LivaNova by 130.5% during the 4th quarter. KBC Group NV now owns 99,928 shares of the company's stock valued at $4,628,000 after buying an additional 56,580 shares in the last quarter. Rhumbline Advisers increased its stake in LivaNova by 0.5% in the 4th quarter. Rhumbline Advisers now owns 177,938 shares of the company's stock worth $8,240,000 after acquiring an additional 899 shares during the last quarter. Finally, PNC Financial Services Group Inc. raised its holdings in shares of LivaNova by 29.1% during the 4th quarter. PNC Financial Services Group Inc. now owns 6,311 shares of the company's stock worth $292,000 after acquiring an additional 1,424 shares in the last quarter. Hedge funds and other institutional investors own 97.64% of the company's stock.

Analysts Set New Price Targets

LIVN has been the topic of several research reports. Mizuho reduced their price target on shares of LivaNova from $70.00 to $60.00 and set an "outperform" rating on the stock in a research report on Wednesday, February 26th. Wolfe Research cut shares of LivaNova from an "outperform" rating to a "peer perform" rating in a research report on Wednesday, February 26th. StockNews.com upgraded LivaNova from a "buy" rating to a "strong-buy" rating in a research report on Tuesday, March 25th. The Goldman Sachs Group decreased their price objective on LivaNova from $64.00 to $55.00 and set a "buy" rating on the stock in a research report on Monday, March 3rd. Finally, Stifel Nicolaus dropped their target price on LivaNova from $72.00 to $60.00 and set a "buy" rating for the company in a report on Wednesday, February 26th. Two equities research analysts have rated the stock with a hold rating, five have given a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, LivaNova has a consensus rating of "Buy" and a consensus price target of $61.17.

Remove Ads

LivaNova Trading Up 1.2 %

Shares of LIVN stock traded up $0.47 on Wednesday, reaching $39.50. 492,975 shares of the company's stock were exchanged, compared to its average volume of 610,784. The company's fifty day simple moving average is $43.94 and its 200 day simple moving average is $48.29. LivaNova PLC has a 52 week low of $36.85 and a 52 week high of $64.48. The company has a current ratio of 3.37, a quick ratio of 2.87 and a debt-to-equity ratio of 0.46. The stock has a market capitalization of $2.15 billion, a PE ratio of 94.05 and a beta of 1.10.

LivaNova Profile

LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.